Odyssey Therapeutics
Cambridge
About Odyssey Therapeutics
Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next-generation immunomodulators and oncology medicines. Odyssey is making a transformational impact on the field of drug discovery and is accelerating the path to clinical development to drive the creation of more effective precision medicines. The company's integrated drug-hunting engine is designed to accelerate drug discovery by unlocking targets with great potential and minimizing attrition.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $700.0M
- Funding stage: Late Stage Venture
- Last round: Series D (Sep 2025)
- Website: odysseytx.com
- Phone: (617) 865-9628
Industries & Categories
Biotechnology, Health Care, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/odyssey-therapeutics-51837 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.